Organic electroluminescent materials and devices
US-2017352809-A1 · Dec 7, 2017 · US
US12250875B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12250875-B2 |
| Application number | US-202318504375-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 8, 2023 |
| Priority date | Aug 15, 2019 |
| Publication date | Mar 11, 2025 |
| Grant date | Mar 11, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided are compounds comprising a ligand L A of Formula I where the ligand L A is coordinated to Ir.
Opening claim text (preview).
What is claimed is: 1. A compound comprising a ligand L A of Formula I wherein: A is a 5-membered or 6-membered carbocyclic or heterocyclic ring; Z 3 and Z 2 are each independently C or N; K 3 and Ware each independently a direct bond, O, or S; X 1 , X 2 , and X 3 are each independently C or N, at least one of X′, X 2 , and X 3 is C; X is O or NR′; R A and R B each represents zero, mono, or up to the maximum number of allowed substitutions to its associated ring; each of R, R′, R A , and R B is independently a hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and two adjacent groups can be joined or fused to form a ring wherever chemically feasible, wherein the ligand L A is complexed to a metal M to form a chelate ring as indicated by the two dotted lines; the metal M can be coordinated to other ligands; the metal M is Ir; and the ligand L A can be linked with other ligands to form a tridentate, tetradentate, pentadentate, or hexadentate ligand. 2. The compound of claim 1 , wherein each R, R′, R A and R B are independently selected from the group consisting of deuterium, fluorine, alkyl, cycloalkyl, heteroalkyl, alkoxy, aryloxy, amino, silyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, aryl, heteroaryl, nitrile, isonitrile, sulfanyl, and combinations thereof. 3. The compound of claim 1 , wherein Z 1 is N, and Z 2 is C. 4. The compound of claim 1 , wherein Z 1 is C, and Z 2 is N. 5. The compound of claim 1 , wherein X 1 -X 3 are all C. 6. The compound of claim 1 , wherein ring A is pyridine, pyrimidine, pyrazine, imidazole, pyrazole, oxazole, thiazole, or imidazole derived carbene. 7. The compound of claim 1 , wherein X is NR′. 8. The compound of claim 7 , wherein R′ and R can be joined to form a ring wherever chemically feasible. 9. The compound of claim 1 , wherein Z 2 and X 1 -X 3 are all C. 10. The compound of claim 1 , wherein each of K 3 and K 4 is a direct bond. 11. The compound of claim 1 , wherein one of K 3 and K 4 is O. 12. The compound of claim 1 , wherein the ligand L A is selected from the group consisting of: wherein: R G for each occurrence represents zero, mono, or up to the maximum number of allowed substitutions to its associated ring; and each of R″ and R G is independently a hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, boryl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and two adjacent R G groups can be joined together to form a ring wherever chemically feasible. 13. The compound of claim 1 , wherein the ligand L A is selected from the group consisting of the following structures: Ligand naming convention Structure L A 1-(j)(k)(p)(z), wherein each of j, k, p, and z is independently an integer from 1 to 55, wherein L A 1-(1)(1)(1)(1) to L A 1-(55)(55)(55)(55) having the structure wherein Rj = Bj, Rk = Bk, Rp = Bp, and Rz = Bz, and L A 2-(j)(k)(p), wherein each of j, k, and p is independently an integer from 1 to 55, wherein L A 2-(1)(1)(1) to L A 2-(55)(55)(55) having the structure wherein Rj = Bj, Rk = Bk, and Rp = Bp, and L A 3-(j)(z), wherein each of j, and z is independently an integer from 1 to 55, wherein L A 3-(1)(1) to L A 3-(55)(55) having the structure wherein Rj = Bj, and Rz = Bz, and L A 4-(j), wherein j is an integer from 1 to 55, wherein L A 4-(1) to L A 4-(55) having the structure wherein Rj = Bj, and L A 5-(j)(k), wherein each of j, and k is independently an integer from 1 to 55, wherein L A 5-(1)(1) to L A 5-(55)(55) having the structure wherein Rj = Bj, and Rk = Bk, and L A 6-(j)(k)(p)(z), wherein each of j, k, p, and z is independently an integer from 1 to 55, wherein L A 6-(1)(1)(1)(1) to L A 6-(55)(55)(55)(55) having the structure wherein Rj = Bj, Rk = Bk, Rp = Bp, and Rz = Bz, and L A 7-(j)(k)(p), wherein each of j, k, and p is independently an integer from 1 to 55, wherein L A 7-(1)(1)(1) to L A 7-(55)(55)(55) having the structure wherein Rj = Bj, Rk = Bk, and Rp = Bp, and L A 8-(j)(k)(z), wherein each of j, k, and z is independently an integer from 1 to 55, wherein L A 8-(1)(1)(1) to L A 8-(55)(55)(55) having the structure
Organoboranes · CPC title
containing six or more rings · CPC title
containing more than one polycyclic condensed aromatic rings, e.g. bis-anthracene · CPC title
Organosilicon compounds, e.g. TIPS pentacene · CPC title
containing four rings, e.g. pyrene · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.